Megan barely remembers undergoing chemotherapy for Stage 4 Hodgkin lymphoma at City of Hope. It took everything out of her — physically, mentally and emotionally. She was in such a bad place that she's nearly blocked out all memories of that entire six months.
The side effects were grueling, but the chemo worked and she went into remission — until three months later, when her cancer returned. This time, she was given a chance to receive a different form of treatment called immunotherapy.
Today, Megan is a two-time cancer survivor with a bright future ahead of her.
At City of Hope, we're bringing groundbreaking research from the lab bench to the bedside to help people like Megan.
Help us continue this important work. With your support, we will be the first to inject CAR-T cells, a personalized form of immunotherapy, directly into a tumor. It's our hope that solid tumors — including brain tumors, which are one of the most difficult types of cancer to treat — will respond as well to this treatment as blood cancers do.
We believe that the impossible is — in fact — possible. If you do, too, add your name to support groundbreaking cancer research and treatments!
